Xue-Yuan Guo Selected Research

Atrial Fibrillation

1/2024	Catheter ablation of atrial fibrillation in patients with left bundle branch block.
10/2023	Catheter ablation versus medical therapy for atrial fibrillation with prior stroke history: a prospective propensity score-matched cohort study.
10/2023	The ABC-Death Score for Mortality Prediction in Patients With Atrial Fibrillation Undergoing Catheter Ablation.
7/2023	Catheter ablation of atrial fibrillation in patients with autoimmune disease: A propensity score matching study based on the China Atrial Fibrillation Registry.
4/2023	Measurement of Serum Ultra-Sensitive Thyroid-Stimulating Hormone Levels to Determine the Risk for Recurrence of Atrial Fibrillation Following Catheter Ablation in 575 Patients from a Single Center.
2/2023	Association Between Pre-Radiofrequency Catheter Ablation Serum Lipid Levels and Recurrence of Atrial Fibrillation in 412 Patients in Beijing, China: A Single-Center Study.
1/2023	Prospective randomized comparison between upgraded '2C3L' vs. PVI approach for catheter ablation of persistent atrial fibrillation: PROMPT-AF trial design.
4/2022	Impact of Low-density Lipoprotein Cholesterol Levels on Outcomes in Nonvalvular Atrial Fibrillation: Results from the China Atrial Fibrillation Registry Study.
1/2022	Direct autotransfusion in the management of acute pericardial tamponade during catheter ablation for atrial fibrillation: An imperfect but practical method.
1/2022	Outcome of catheter ablation for paroxysmal atrial fibrillation in patients with stable coronary artery disease.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Xue-Yuan Guo Research Topics

Disease

24	Atrial Fibrillation 01/2024 - 08/2014
6	Stroke (Strokes) 10/2023 - 05/2016
4	Tachycardia (Tachyarrhythmias) 01/2023 - 04/2014
3	Thromboembolism 04/2022 - 04/2019
2	Cardiac Tamponade 01/2022 - 11/2021
2	Coronary Artery Disease (Coronary Atherosclerosis) 01/2022 - 10/2021
2	Cardiac Arrhythmias (Arrythmia) 12/2019 - 04/2018
1	Bundle-Branch Block (Fascicular Block) 01/2024
1	Death (Near-Death Experience) 10/2023
1	Autoimmune Diseases (Autoimmune Disease) 07/2023
1	Thrombosis (Thrombus) 01/2022
1	Disseminated Intravascular Coagulation 01/2022
1	Infections 01/2022
1	Fever (Fevers) 01/2022
1	Multiple Organ Failure (MODS) 01/2022
1	Chronic Obstructive Pulmonary Disease (COPD) 01/2022
1	Venous Thrombosis (Deep-Vein Thrombosis) 01/2022
1	Hemorrhage 11/2021
1	Dextrocardia 01/2021
1	Sick Sinus Syndrome 01/2021
1	Situs Inversus 01/2021
1	Sudden Infant Death (SID) 01/2021
1	Heart Failure 04/2019
1	Peptic Ulcer (Peptic Ulcers) 04/2019
1	Transient Ischemic Attack 10/2016
1	Overweight 10/2016
1	Coronary Disease (Coronary Heart Disease) 10/2016
1	Hypertension (High Blood Pressure) 10/2016
1	Cardiovascular Diseases (Cardiovascular Disease) 10/2016
1	Embolism (Embolus) 10/2016
1	Bradycardia 04/2014

Drug/Important Bio-Agent (IBA)

3	LipidsIBA 02/2023 - 06/2018
3	Warfarin (Coumadin)FDA LinkGeneric 04/2019 - 05/2016
2	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2022 - 10/2016
2	Dabigatran FDA Link 11/2021 - 10/2018
2	AnticoagulantsIBA 04/2019 - 05/2016
1	Biomarkers (Surrogate Marker)IBA 10/2023
1	Thyrotropin (Thyroid-Stimulating Hormone)FDA Link 04/2023
1	Ethanol (Ethyl Alcohol)IBA 01/2023
1	AntralIBA 01/2023
1	LDL CholesterolIBA 04/2022
1	oxidized low density lipoproteinIBA 04/2022
1	APTIBA 01/2022
1	idarucizumabIBA 11/2021
1	IceIBA 12/2019
1	4- ethyl- 6- oxa- 1- azatricyclo(4.2.2.0)dodecan- 5- one (AF 3)IBA 04/2019
1	N(4)-oleylcytosine arabinosideIBA 04/2019
1	CoagulantsIBA 10/2018
1	Triiodothyronine (Liothyronine)FDA LinkGeneric 04/2018
1	Thyroid HormonesIBA 04/2018
1	Unsaturated Fatty Acids (Polyunsaturated Fatty Acids)IBA 08/2014
1	Omega-3 Fatty Acids (Omega 3 Fatty Acids)IBA 08/2014
1	AntioxidantsIBA 08/2014
1	VitaminsIBA 08/2014
1	Anti-Arrhythmia AgentsIBA 04/2014

Therapy/Procedure

17	Catheter Ablation 01/2024 - 04/2014
6	Therapeutics 10/2023 - 05/2016
3	Catheters 10/2023 - 12/2019
1	Autologous Blood Transfusion 01/2022
1	Length of Stay 01/2022
1	Perioperative Period 11/2021
1	Drug Therapy (Chemotherapy) 10/2021